HTAi 2011


	Bienvenidos
	Tema
	Organizadores
	Comités
	Auspicio y Exposición
	Programa Cientifico
	- Plenarias[NUEVO]
	- Premios
	- Sesiones Orales[NUEVO]
	- Paneles[NUEVO]
	Inscripciones
	Actividades Pre-Conferencia
	Trabajos Científicos
	Local
	Alojamiento y Paseos
	Programa Social
	Becas de Viaje
	Información de Viaje
	Compensación de Carbono
	Acerca Rio de Janeiro
	Links de interés
	Contacto
	Login de congresistas

NOTICIAS

Estimado participante,
Su opinión es muy importante para nosotros. Por favor, conteste el cuestionario on-line acerca de su experiencia en la 8ª Conferencia Anual HTAi.
Acceso: http://www.surveymonkey.com
Equipo Organizador del HTAi 2011

SESIONES ORALES

PRESENTACIONES EN PDF

• OS16 - Medicines Policy and Sustainability;
236 - Exceptional Higher Allowed Price of Medicines in Slovenia. Does HTA Fit In? Eva Turk	E.T. PDF version
379 - Multiple Demand Side Measures Needed to Enhance Prescribing of Generics for Sustainable Healthcare: Experiences From Abu Dhabi Brian Godman	B.G. PDF version
448 - Policy Framework for Tiered Pricing to Improve Access and Affordability of Medicines In Low and Middle Income Countries Rutger Daems	R.D. PDF version
660 - Management Model to Replace an Original High Cost Drug for a Generic Formulation. Evaluation, Monitoring and Results Abayubá Perna	A.P.F. PDF version
816 - The Effect of HTA on Reimbursed Pharmaceutical Prices – Preliminary Results from an International Empirical Analysis Peter Davey	P.D. PDF version

• OS17 - Applying of Health Technology Assessment;
594 - Evidence Based Essential Medicines and Herbal Medicines Selection: Training of Brazilian Expert Commissions Marcus Tolentino Silva	M.T.S. PDF version
706 – The Role of DECIT on Decision Making About Incorporation Of Health Technologies In Brazilian Health System In 2010 Flávia Cristina Ribeiro Salomon	F.C.R.S. PDF version

• OS18 - HTA Report Utilization;
304 - Evaluation of Implementation Process of Prenatal Screening in Finland Ulla Saalasti-Koskinen	U.S.K. PDF version
460 - Telemedicine Support on Maternal and Newborn Health in Remote Provinces of Mongolia Oyun Chimeddamba	O.C. PDF version
518 - Review of Decision-Analytic Models in Chronic Myeloid Leukemia Ursula Rochau	U.R. PDF version
736 - Review of Studies on Economic Evaluation of Treatment for Osteoporosis Postmenopausal Cristina Mariano Ruas Brandão	C.M.R.B. PDF version

• OS19 - National Health Policies And HTA Agencies;
214 - North-South and South-South HTA Transferability: The Experiences of Latin American Researchers and Decision-Makers in Using HTA Reports from Other Jurisdictions Andres Pichon-Riviere	A.P. PDF version
393 - Innovative Health Technologies: Criteria and Incentives in France Sun-Hae Lee-Robin	S.H.L.R. PDF version
462 - Accountability for Reasonableness of Drug Reimbursement Systems: Comparison of the Austrian, Belgian, Dutch, French and Swedish System and Development of a Transparency Framework for Decision Making Irina Cleemput	I.C. PDF version
899 - HTA: The Anchor in a Sea Of Political Change Peter Littlejohns	P.L. PDF version
945 - Institutionalizing HTA in Brazil: A Comparative Analysis With the UK, Canada and Australia Vania Cristina Canuto Santos	V.C.C.S. PDF version

• OS20 - HTA and Patient Perspective;
374 - Strategies to Enroll Patients to an Integrated Program for Breast Cancer Care – A Partnership Between Health Services, Schools and a Non-Governmental Organization Camila Cristina Pires Nascimento	C.C.P.N. PDF version
430 - Introducing Patients’ Perspective in Health Technology Assessment at the Local Level: A Qualitative Study Among HTA Producers and Hospital Managers Marie-Pierre Gagnon	M.P.G. PDF version
956 - Ethics and Policy in HTA: Patient Preferences at Odds With HTA- The Example of Autologous Blood Donation for Spinal Fusion David A Wong	D.A.W PDF version

1-2-3-4-5-6